A Boston radiopharmaceuticals startup is aiming to hit the public markets this week, a sign that market conditions may be improving at the start of 2026.
Read More from Bizjournals.com Feed (2025-02-17 17:26:56)
Boston biotech eyes $200M in first Mass. IPO of 2026
